| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |